Apollo Endosurgery (APEN) Misses Q2 EPS by 9c

Apollo Endosurgery (NASDAQ: APEN) reported Q2 EPS of ($0.53), $0.09 worse than the analyst estimate of ($0.44). Revenue for the quarter came in at $15.8 million versus the consensus estimate of $16.64 million.

For earnings history and earnings-related data on Apollo Endosurgery (APEN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79